Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Sugemalimab |
Trade Name | |
Synonyms | WBP3155|CS1001 |
Drug Descriptions |
Sugemalimab (CS1001) is a monoclonal antibody against CD274 (PD-L1) that inhibits binding to the PDCD1 (PD1) receptor, potentially resulting in enhanced anti-tumor immune response (PMID: 28679395). |
DrugClasses | Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 121 |
CAS Registry Number | NA |
NCIT ID | C154550 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cisplatin + Fluorouracil + Sugemalimab | Cisplatin Fluorouracil Sugemalimab | 0 | 0 |
Fisogatinib + Sugemalimab | Fisogatinib Sugemalimab | 0 | 0 |
Regorafenib + Sugemalimab | Regorafenib Sugemalimab | 0 | 1 |
Sugemalimab | Sugemalimab | 0 | 3 |